Abbott Laboratories Inc.’s experimental Absorb heart stent, designed to dissolve and thereby restore the blood vessel’s natural flexibility, has proven safe and effective a year after being implanted in patients, researchers said. Get the full story »
Inside these posts: Stents
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Abbott bets on dissolvable heart stent
Abbott Laboratories is betting heart patients will benefit from a new type of arterial stent that dissolves away when it is no longer needed. Get the full story »
Abbott absorbable heart stent gets European OK
Abbott Laboratories’ said its experimental dissolvable heart stent has received approval in Europe, a key milestone in the development of the next-generation heart device for patients in the U.S. and around the world.
The North Chicago-based drug and medical device giant said it is the first-ever government regulatory approval of an absorbable stent. Get the full story »
Abbott Labs hired cardiologist barred from hospital
Abbott Laboratories hired a Baltimore-area cardiologist as a sales consultant after he was barred from practicing at a local hospital last year for allegedly putting heart stents in hundreds of patients who didn’t need them, say Senate investigators probing the medical-device industry.
Their report, to be released Monday, shines a light on one of the most lucrative procedures for hospitals and medical-device makers, at a time of spiraling health-care costs. Medicare paid some $25.7 billion for stent surgery in the six years through 2009, according to the report. Get the full story »
Drug-coated stents safe for large heart arteries
Drug-coated heart stents, such as the Xience model made by Abbott Labs, are as safe as the old bare metal variety for patients with narrowed large coronary arteries, a large European study showed, alleviating concerns about their long-term use.
There was no increase in the number of deaths or heart attacks two years after the drug-coated stent was implanted, according to data presented at the scientific sessions of the American Heart Association in Chicago. Get the full story »
